Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0C67
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,880
Award facts
- Contract value 100% obligated
- $1,880.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,880.47 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 8, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to the Department of Defense, including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals supporting military healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The parent IDC, awarded November 13, 2025, carries a $499.99 billion ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As one of multiple regional prime vendor contractors under this strategic program, DMS Pharmaceutical Group serves as a critical supplier enabling the Defense Logistics Agency to efficiently distribute diverse and specialized pharmaceutical requirements across the federal military medical system with no identified subcontractors.
Quick answers
Who was awarded contract SPE2DU26F0C67?
SPE2DU26F0C67 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 8, 2025.
How much is contract SPE2DU26F0C67 worth?
The government has obligated $1,880 on SPE2DU26F0C67.
Is contract SPE2DU26F0C67 an order under another contract?
Yes. SPE2DU26F0C67 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0C67 competed?
The extent of competition for SPE2DU26F0C67 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award